Stocks
Roche Holding (RHHBY) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 260.9% | 194.5% | 325.3% | 352.0% | 305.4% | 311.8% | |||
| Changes by years, y/y, % | +15pp | -66pp | +131pp | +27pp | -47pp | +4.5% | |||
Roche Holding. R&D/CAPEX, %
Roche Holding. R&D/CAPEX, changes, pp
Roche Holding (RHHBY) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | LTM ? | |||
| R&D/CAPEX, % | 293.8% | 397.6% | 318.8% | 363.7% | 259.3% | 311.8% | ||
| Changes by years, y/y, % | -134pp | -34pp | ||||||
| Changes by quarters, q/q, % | -204pp | +104pp | -79pp | +45pp | -104pp | |||
